Full-Time

Project Manager

Cardiovascular Safety Services

Posted on 8/9/2025

Celerion

Celerion

1,001-5,000 employees

Global CRO for early-phase development

No salary listed

Tempe, AZ, USA

Hybrid

Candidates should be local to the Phoenix area.

Category
Business & Strategy (1)
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree in Life Sciences or related field required
  • Excellent computer skills and proficient in Excel, Word, Outlook, and Access
  • Excellent communication skills both verbal and written
  • Demonstrated leadership and vision in managing staff groups and major projects or initiatives
  • Excellent interpersonal skills and a collaborative management style
  • Ability to challenge and debate issues of importance to the organization
  • Proven organizational and multi-tasking ability
  • Proven negotiation skills
  • Conflict Management
  • Minimum of 3 years ECG Core Lab Project Management experience preferred
  • Ability to manage multiple priorities
  • Excellent leadership skills with the ability to influence and lead in a team environment
  • Flexibility of hours required
Responsibilities
  • Responsible for staff management including interviewing, hiring, and training employees; planning, assigning and directing work; appraising performance; rewarding and disciplining employees; addressing complaints and resolving problems; development and coaching of employees
  • Identify, implement and track new directives for department efficiency and growth
  • Delegate project tasks, as required
  • Monitor adherence to rules, regulations, procedures and project timelines
  • Coordinate and successfully communicate project responsibilities and timelines with all support divisions and external vendors to ensure successful project execution
  • Review fee proposals
  • Oversee logistical design and feasibility of ECG Core Lab studies
  • Communicate ECG Core Lab requirements to external vendors and collaborate to develop mutually beneficial objectives
  • Review, evaluate and improve the operational systems, processes and policies in support of organizational objectives and to improve operational output
  • Monitor department productivity, as well as, personnel growth and advancement opportunities
  • Assist in creating annual department budget
  • Contribute to short and long-term organizational planning and strategy as a member of the management team
  • Implement software validation and rollouts by performing risk assessments, developing user requirements and playing a major role in software validation
  • Coordinate with external vendors to perform software installations, software patches or root cause investigations
  • Coordinate with IT department to insure proper installation and function of digital ECG software, Web service interface and portal access
  • Represent the ECG Core Lab and discuss cardiovascular safety services with clients during internal site visits
  • Respond to client inquiries regarding operational elements and capabilities of the ECG Core Lab and other cardiovascular service offerings
  • Oversee resource allocation, team coordination, and standardization for all ECG Core Lab projects
  • Provide training, mentorship, and client support
  • Handle special project situations and perform Project Manager duties as needed
  • Review protocols, specifications, and T/E as needed
  • Secure sponsor approval via Study Configuration Form
  • Ensure software, devices, and supplies are ready for all ECG Core Lab studies
  • Perform Project Manager duties when required
  • Ensure adherence to protocols, SOPs, and regulations
  • Oversee HL7 file creation, FDA submissions, and timely responses to QA audits and data edit checks
Desired Qualifications
  • Minimum of 3 years ECG Core Lab Project Management experience preferred

Celerion is a global contract research organization focused on early-phase drug development. It supports pharmaceutical and biotech clients with trial design, feasibility, project management, clinical and medical monitoring, bioanalytical sciences, and regulatory affairs, all conducted under contract. Its work hinges on metabolite profiling using high-resolution mass spectrometry to inform development decisions. With 40+ years of experience and a global, integrated service network, Celerion aims to help clients bring safe, effective treatments to patients faster by delivering rigorous, timely research.

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

N/A

Headquarters

Lincoln, Nebraska

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • THL Partners' acquisition post-H.I.G. 2022 investments accelerates Celerion's global expansion.
  • Labnotes software enhanced May 6, 2025, streamlines bioanalytical data for faster sponsor decisions.
  • GLP/GCP molecular testing expansion supports surging cell/gene therapy demand in Lincoln/Zürich.

What critics are saying

  • THL Partners cuts costs post-acquisition, eroding Celerion employee retention within 12-24 months.
  • WuXi AppTec Belfast expansion captures EU clients with 40% lower HRMS pricing in 6-12 months.
  • FDA AI audits expose Labnotes flaws, holding 30% bioanalytical submissions for 6 months.

What makes Celerion unique

  • Celerion pioneered VCT biometric fingerprint technology, verifying 50,000 participants over five years.
  • Celerion earned first US CRO full AAHRPP accreditation, exceeding federal participant protections.
  • Celerion leads early-phase CROs with 650+ beds across North America, Europe, and Asia.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

4%
PharmiWeb.com
May 7th, 2025
Celerion Launches Enhanced Version Of Labnotes Bioanalytical Data Management Software

LINCOLN, Neb.; May 6, 2025 (Business Wire) – Celerion, a global leader in early clinical research and bioanalytical services, announced the launch of the latest version of Labnotes, its cutting-edge bioanalytical electronic laboratory notebook software elevating data handling and analysis capabilities for sponsors. The latest system enhancements streamline laboratory documentation and improve operational efficiency for users. The updated platform also offers advanced tools for handling and organizing large datasets, ensuring faster processing of reports and optimized database queries

Instrument Business Outlook
May 6th, 2025
Celerion Launches Enhanced Version of Labnotes Bioanalytical Data Management Software

Celerion launches enhanced version of labnotes bioanalytical data Management software.

Business Wire
Jun 5th, 2024
Celerion Honored With Prestigious CRO Leadership Award for Ninth Consecutive Year

Celerion was recognized as a CRO Leader in the quality, capabilities and reliability categories across two groups of respondents (small pharma and combined big and small pharma).

Business Wire
May 7th, 2024
Jo Goodman Joins Celerion as Vice President of Bioanalytical Services

Celerion announced the appointment of Jo Goodman as vice president of bioanalytical services in its Lincoln, Nebraska, laboratory.Post this

Business Wire
May 7th, 2024
Jo Goodman Joins Celerion As Vice President Of Bioanalytical Services

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, a leading clinical research organization, specializing in early clinical research and bioanalytical services, today announced the appointment of Jo Goodman as vice president of bioanalytical services in its Lincoln, Nebraska, laboratory. In her new role, Goodman will oversee the strategic direction and operational performance of the Lincoln bioanalytical laboratory, leveraging her extensive experience in pharmaceutical research and development to drive innovation and design and execute customized bioanalysis for clients’ needs. She will be responsible for delivering on Celerion’s bioanalytical promise of industry-leading science, stringent compliance, and speed of delivery. With over 29 years of experience in the pharmaceutical industry, Goodman brings a wealth of knowledge in regulated GxP and discovery bioanalysis for both in-house and outsourced activities. Prior to joining Celerion, she held positions of increasing responsibility at AstraZeneca, MedImmune, and GlaxoSmithKline. Additionally, Goodman is a recognized thought leader, having recently served as a member of the Expert Working Group (EWG) for ICH M10 Bioanalytical Guidance Development and is active in numerous non-profit industry consortia such as EBF, AAPS, and DMDG

INACTIVE